These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 37981219)
1. Insight into the Role of Gut Microbiota in Duchenne Muscular Dystrophy: An Age-Related Study in Mdx Mice. Jollet M; Mariadassou M; Rué O; Pessemesse L; Ollendorff V; Ramdani S; Vernus B; Bonnieu A; Bertrand-Gaday C; Goustard B; Koechlin-Ramonatxo C Am J Pathol; 2024 Feb; 194(2):264-279. PubMed ID: 37981219 [TBL] [Abstract][Full Text] [Related]
2. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy. Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351 [TBL] [Abstract][Full Text] [Related]
3. Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice. Farini A; Tripodi L; Villa C; Strati F; Facoetti A; Baselli G; Troisi J; Landolfi A; Lonati C; Molinaro D; Wintzinger M; Gatti S; Cassani B; Caprioli F; Facciotti F; Quattrocelli M; Torrente Y EMBO Mol Med; 2023 Mar; 15(3):e16244. PubMed ID: 36533294 [TBL] [Abstract][Full Text] [Related]
4. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy. Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761 [TBL] [Abstract][Full Text] [Related]
16. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles? Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers. Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869 [TBL] [Abstract][Full Text] [Related]
18. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. Tidball JG; Wehling-Henricks M Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129 [TBL] [Abstract][Full Text] [Related]
19. Protein-DNA array-based identification of transcription factor activities differentially regulated in skeletal muscle of normal and dystrophin-deficient mdx mice. Dogra C; Srivastava DS; Kumar A Mol Cell Biochem; 2008 May; 312(1-2):17-24. PubMed ID: 18278580 [TBL] [Abstract][Full Text] [Related]
20. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy. Ito M; Ehara Y; Li J; Inada K; Ohno K Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]